AI brief of an SEC Form 8-K · NU SKIN ENTERPRISES, INC. (NUS)

Nu Skin posts Q2 loss of $5.14 per share on 17.1% revenue drop

Negative Impact 4 of 5 earnings Written later

Nu Skin reported second-quarter 2026 revenue of $320.1 million, down 17.1% from $386.1 million, and a GAAP net loss of $249.8 million, or $5.14 per share, driven by a $78.9 million impairment charge and a $167.5 million tax charge for a valuation allowance on deferred tax assets. Excluding these charges, adjusted EPS was $0.20 versus $0.43 a year earlier, and the company set 2026 revenue guidance of $1.28 billion to $1.35 billion and adjusted EPS of $0.70 to $0.90.

Key points

Q2 2026 revenue was $320.1 million, down 17.1%, including a $4.0 million foreign exchange impact
GAAP EPS was $(5.14) versus $0.43; EPS excluding impairment and non-cash tax charges was $0.20
Q3 2026 guidance: revenue of $310 million to $340 million and adjusted EPS of $0.10 to $0.20
Full-year 2026 guidance: revenue of $1.28 billion to $1.35 billion, down 14% to 9%, and adjusted EPS of $0.70 to $0.90

The filing

CompanyNU SKIN ENTERPRISES, INC. (NUS)

Form8-K, current report

Filed with the SECAug 10, 2026, 4:15 PM ET

Accession number0001140361-26-032025

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 10, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.